These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7840185)

  • 1. Effect of prednisone on protein metabolism in Duchenne dystrophy.
    Rifai Z; Welle S; Moxley RT; Lorenson M; Griggs RC
    Am J Physiol; 1995 Jan; 268(1 Pt 1):E67-74. PubMed ID: 7840185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased turnover of muscle contractile proteins in Duchenne muscular dystrophy as assessed by 3-methylhistidine and creatinine excretion.
    Ballard FJ; Tomas FM; Stern LM
    Clin Sci (Lond); 1979 Apr; 56(4):347-52. PubMed ID: 477220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of muscle wasting in myotonic dystrophy.
    Griggs RC; Jozefowicz R; Kingston W; Nair KS; Herr BE; Halliday D
    Ann Neurol; 1990 May; 27(5):505-12. PubMed ID: 2360792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased rates of myofibrillar protein breakdown in muscle-wasting diseases.
    Warnes DM; Tomas FM; Ballard FJ
    Muscle Nerve; 1981; 4(1):62-6. PubMed ID: 7231447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Branched-chain ketoacids reduce muscle protein degradation in Duchenne muscular dystrophy.
    Stewart PM; Walser M; Drachman DB
    Muscle Nerve; 1982 Mar; 5(3):197-201. PubMed ID: 7088016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased myofibrillar protein catabolism in duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    Mussini E; Cornelio F; Colombo L; De Ponte G; Giudici G; Cotellessa L; Marcucci F
    Muscle Nerve; 1984 Jun; 7(5):388-91. PubMed ID: 6738577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pilot trial of prednisone in facioscapulohumeral muscular dystrophy. FSH-DY Group.
    Tawil R; McDermott MP; Pandya S; King W; Kissel J; Mendell JR; Griggs RC
    Neurology; 1997 Jan; 48(1):46-9. PubMed ID: 9008492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-methylhistidine excretion in myotonic dystrophy.
    Griggs RC; Moxley RT; Forbes GB
    Neurology; 1980 Dec; 30(12):1262-7. PubMed ID: 7192806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prednisone in Duchenne dystrophy. A randomized, controlled trial defining the time course and dose response. Clinical Investigation of Duchenne Dystrophy Group.
    Griggs RC; Moxley RT; Mendell JR; Fenichel GM; Brooke MH; Pestronk A; Miller JP
    Arch Neurol; 1991 Apr; 48(4):383-8. PubMed ID: 2012511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single skinned muscle fibers in Duchenne muscular dystrophy generate normal force.
    Horowits R; Dalakas MC; Podolsky RJ
    Ann Neurol; 1990 Jun; 27(6):636-41. PubMed ID: 2360800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical investigation of Duchenne muscular dystrophy. Interesting results in a trial of prednisone.
    Brooke MH; Fenichel GM; Griggs RC; Mendell JR; Moxley RT; Miller JP; Kaiser KK; Florence JM; Pandya S; Signore L
    Arch Neurol; 1987 Aug; 44(8):812-7. PubMed ID: 3632393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy.
    Mendell JR; Moxley RT; Griggs RC; Brooke MH; Fenichel GM; Miller JP; King W; Signore L; Pandya S; Florence J
    N Engl J Med; 1989 Jun; 320(24):1592-7. PubMed ID: 2657428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinction between Duchenne and other muscular dystrophies by ribosomal protein synthesis.
    Ionasescu V
    J Med Genet; 1975 Mar; 12(1):49-54. PubMed ID: 164552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral glutamine slows down whole body protein breakdown in Duchenne muscular dystrophy.
    Hankard RG; Hammond D; Haymond MW; Darmaun D
    Pediatr Res; 1998 Feb; 43(2):222-6. PubMed ID: 9475288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term effects of corticosteroid therapy on cardiac and skeletal muscles in muscular dystrophies.
    Hussein G; Mansour L; Ghafar HA; Mostafa FA; Fawaz L
    J Investig Med; 2014 Aug; 62(6):875-9. PubMed ID: 24866459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein metabolism in Duchenne muscular dystrophy, monoclonal and mixed skeletal muscle cultures.
    Corbett AJ
    Clin Exp Neurol; 1987; 24():214-9. PubMed ID: 3268348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of testosterone on muscle mass and muscle protein synthesis.
    Griggs RC; Kingston W; Jozefowicz RF; Herr BE; Forbes G; Halliday D
    J Appl Physiol (1985); 1989 Jan; 66(1):498-503. PubMed ID: 2917954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased myofibrillar protein catabolism in Duchenne muscular dystrophy measured by 3-methylhistidine excretion in the urine.
    McKeran RO; Halliday D; Purkiss P
    J Neurol Neurosurg Psychiatry; 1977 Oct; 40(10):979-81. PubMed ID: 591977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term benefit from prednisone therapy in Duchenne muscular dystrophy.
    Fenichel GM; Florence JM; Pestronk A; Mendell JR; Moxley RT; Griggs RC; Brooke MH; Miller JP; Robison J; King W
    Neurology; 1991 Dec; 41(12):1874-7. PubMed ID: 1745340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne muscular dystrophy. CIDD Study Group.
    Kissel JT; Burrow KL; Rammohan KW; Mendell JR
    Neurology; 1991 May; 41(5):667-72. PubMed ID: 2027481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.